Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smartrac Technology is a global leader in the development and manufacture of RFID (Radio Frequency Identification) and IoT solutions, providing digital identities for a wide range of applications in healthcare and life sciences. The company's technology is utilized for pharmaceutical anti-counterfeiting, laboratory sample tracking, and the management of medical devices and hospital assets. By integrating NFC and RFID transponders into healthcare products, Smartrac enables real-time visibility, enhanced supply chain security, and improved patient safety. In March 2020, Smartrac's RFID Transponder business was acquired by Avery Dennison, creating one of the world's largest players in intelligent labeling. The company's solutions continue to support digital transformation in clinical settings and pharmaceutical manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smartrac Technology.